TD Cowen Maintains Buy on Versigent, Raises Price Target to $58

Benzinga Newsdesk www.benzinga.com Positive 75.4%

Neg 0% Neu 0% Pos 75.4%

TD Cowen analyst Itay Michaeli maintains Versigent (NYSE:VGNT) with a Buy and raises the price target from $49 to $58.

Comments

No comments yet. Be the first!